Myasthenia gravis trials in Brazil
3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)
- Where
- Salvador, São Paulo
- Age
- 2 years to 17 years
- People
- 15 worldwide
- Run by
- Amgen
See details and how to joinNCT06987539 · EU 2025-520993-20-00 - Phase 2/3Taking peopleKYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
- Where
- São Paulo
- Age
- 18 years to 75 years
- People
- 66 worldwide
- Run by
- Kyverna Therapeutics
See details and how to joinNCT06193889 · EU 2023-509892-17-00 - Phase 3Taking peoplePK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis
- Where
- Joinville, Salvador, São José do Rio Preto, São Paulo
- Age
- 6 years to 17 years
- People
- 12 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT06607627 · EU 2024-515157-17-00